So I guess the thought is that as soon as a placebo patient gets worse.....to switch then to Leronlimab ASAP before it's too late while those lucky 2/3 of patients will hopefully improve without getting worse ?
Imagine that -- we prove how well Leronlimab works without any doubts. This would be amazing!

But -- when can that trial start? Do we have to completely enroll all 342 and all start at the same time?